Acute kidney injury following cancer immunotherapy; collaboration of oncologists and nephrologists

Acute kidney injury (AKI) is a known complication of cancer immunotherapy, which is a type of cancer treatment that uses the body’s immune system to fight cancer cells. The mechanism of acute kidney injury (AKI) in cancer immunotherapy is thought to be related to the immune-mediated inflammation and cytokine release that can occur with immunotherapy. This inflammation can damage the kidney tubules and impair kidney function.